Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
plus icon
bookmark
Share icon

In this episode, we discuss PCSK9 inhibitors, a new drug class for LDL lowering, with a particular focus on alirocumab (Praluent).

10/13/15 • 32 min

plus icon
bookmark
Share icon

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/helixtalk-rosalind-franklin-universitys-college-of-pharmacy-podcast-59455/033-pcsk9-inhibitors-3093457"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to 033 - pcsk9 inhibitors on goodpods" style="width: 225px" /> </a>

Copy